Five Prime Therapeutics Inc (NASDAQ:FPRX)

Delayed Data
As of 4:00pm ET
 -0.84 / -4.98%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 49.00, with a high estimate of 65.00 and a low estimate of 25.00. The median estimate represents a +205.49% increase from the last price of 16.04.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.21%
Growthannually 24.95%


Growthquarterly -27.37%
Growthannually 90.53%
Key to the earnings and sales forecast charts.